DaVita Inc. (LON:0I7E)
London · Delayed Price · Currency is GBP · Price in USD 145.89
+1.31 (0.91%)
At close: Jul 28, 2025
DaVita Market Cap
DaVita has a market cap or net worth of 7.89 billion as of August 1, 2025. Its market cap has decreased by -16.20% in one year.
Market Cap
7.89B
Enterprise Value
18.26B
Revenue
10.04B
Ranking
n/a
PE Ratio
11.86
Stock Price
145.89
Market Cap Chart
Since October 31, 1995, DaVita's market cap has increased from 275.69M to 7.89B, an increase of 2,763.05%. That is a compound annual growth rate of 11.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 7.89B | -19.42% |
| Dec 31, 2024 | 9.80B | 30.38% |
| Dec 29, 2023 | 7.51B | 34.54% |
| Dec 30, 2022 | 5.58B | -34.77% |
| Dec 31, 2021 | 8.56B | -11.11% |
| Dec 31, 2020 | 9.63B | 32.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.60B |
| GSK plc | 57.26B |
| Haleon | 32.31B |
| Smith & Nephew | 10.17B |
| ConvaTec Group | 4.77B |
| Hikma Pharmaceuticals | 4.33B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.96B |